Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
-
- Florian Krammer
- Department of Microbiology Icahn School of Medicine at Mount Sinai New York City NY USA
-
- Jerry P. Weir
- Division of Viral Products, Food and Drug Administration Bethesda MD USA
-
- Othmar Engelhardt
- Division of Virology National Institute for Biological Standards and Control Potters Bar UK
-
- Jacqueline M. Katz
- Formerly Influenza Branch Centers for Disease Control and Prevention (CDC) Atlanta GA USA
-
- Rebecca Jane Cox
- Department of Clinical Science Influenza Centre University of Bergen Bergen Norway
説明
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>This report summarizes the discussions and conclusions from the “<jats:italic>Immunological Assays and Correlates of Protection for Next‐Generation Influenza Vaccines”</jats:italic> meeting which took place in Siena, Italy, from March 31, 2019, to April 2, 2019.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Furthermore, we review current correlates of protection against influenza virus infection and disease and their usefulness for the development of next generation broadly protective and universal influenza virus vaccines.</jats:p></jats:sec>
収録刊行物
-
- Influenza and Other Respiratory Viruses
-
Influenza and Other Respiratory Viruses 14 (2), 237-243, 2019-12-13
Wiley